| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
General Counsel
1 company
Smith Jason Drew is a General Counsel at UroGen Pharma Ltd.. Recent SEC Form 4 filings include 1 buy and 1 sell.
Estimated insider holdings value: $1.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 30, 2021 | URGN Urogen Pharma Ltd. | General Counsel | Sale+OE | 3,803 | $12.03 | $45,750.09 | -35.1% | -50.4% | -29.1% | |
| May 17, 2021 | URGN Urogen Pharma Ltd. | General Counsel | Buy | 2,500 | $15.71 | $39,275.00 | New | -6.5% | -63.2% |